PT117220A - DISINFECTANT SOLUTION COMPRISING ALCOHOL AND CHITOSAN - Google Patents
DISINFECTANT SOLUTION COMPRISING ALCOHOL AND CHITOSANInfo
- Publication number
- PT117220A PT117220A PT117220A PT11722021A PT117220A PT 117220 A PT117220 A PT 117220A PT 117220 A PT117220 A PT 117220A PT 11722021 A PT11722021 A PT 11722021A PT 117220 A PT117220 A PT 117220A
- Authority
- PT
- Portugal
- Prior art keywords
- chitosan
- alcohol
- kda
- preferentially
- disinfectant solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
Abstract
A PRESENTE INVENÇÃO DESCREVE UMA SOLUÇÃO QUE COMPREENDE ÁLCOOL E QUITOSANO E/OU DERIVADO(S) DE QUITOSANO; EM QUE O QUITOSANO TEM UM PESO MOLECULAR DE 100 KDA A 500 KDA, PREFERENCIALMENTE DE 150 KDA E 350 KDA; EM QUE O GRAU DE DESACETILAÇÃO DO QUITOSANO É DE PELO MENOS 50%, PREFERENCIALMENTE DE 70 A 99%, E AINDA MAIS PREFERENCIALMENTE DE 80 A 98%; EM QUE A RELAÇÃO PERCENTUAL ENTRE O QUITOSANO E/OU DERIVADO(S) DE QUITOSANO:ÁLCOOL É DE 50:50 A 10:90, PREFERENCIALMENTE DE 40:60 A 20:80; E EM QUE A CONCENTRAÇÃO DE QUITOSANO EM RELAÇÃO À FASE AQUOSA/ÁCIDA É PELO MENOS 0,01%. A PRESENTE INVENÇÃO DESCREVE TAMBÉM UM PROCESSO DE OBTENÇÃO DA SOLUÇÃO AQUI DESCRITA E A SUA UTILIZAÇÃO PARA DESINFEÇÃO DE SUPERFÍCIES.THE PRESENT INVENTION DESCRIBES A SOLUTION COMPRISING ALCOHOL AND CHITOSAN AND/OR CHITOSAN DERIVATIVE(S); IN WHICH THE CHITOSAN HAS A MOLECULAR WEIGHT FROM 100 KDA TO 500 KDA, PREFERENTIALLY FROM 150 KDA AND 350 KDA; IN WHICH THE DEGREE OF DEACETYLATION OF THE CHITOSAN IS AT LEAST 50%, PREFERENTLY FROM 70 TO 99%, AND EVEN MORE PREFERENTIALLY FROM 80 TO 98%; IN WHICH THE PERCENTAGE RATIO BETWEEN CHITOSAN AND/OR CHITOSAN DERIVATIVE(S):ALCOHOL IS FROM 50:50 TO 10:90, PREFERENTIALLY FROM 40:60 TO 20:80; AND IN WHICH THE CONCENTRATION OF CHITOSAN RELATED TO THE AQUEOUS/ACID PHASE IS AT LEAST 0.01%. THE PRESENT INVENTION ALSO DESCRIBES A PROCESS FOR OBTAINING THE SOLUTION DESCRIBED HEREIN AND ITS USE FOR SURFACES DISINFECTION.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT117220A PT117220A (en) | 2021-05-11 | 2021-05-11 | DISINFECTANT SOLUTION COMPRISING ALCOHOL AND CHITOSAN |
PCT/IB2021/054772 WO2022238739A1 (en) | 2021-05-11 | 2021-05-31 | Disinfectant solution comprising alcohol and chitosan |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT117220A PT117220A (en) | 2021-05-11 | 2021-05-11 | DISINFECTANT SOLUTION COMPRISING ALCOHOL AND CHITOSAN |
Publications (1)
Publication Number | Publication Date |
---|---|
PT117220A true PT117220A (en) | 2023-01-18 |
Family
ID=76523247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT117220A PT117220A (en) | 2021-05-11 | 2021-05-11 | DISINFECTANT SOLUTION COMPRISING ALCOHOL AND CHITOSAN |
Country Status (2)
Country | Link |
---|---|
PT (1) | PT117220A (en) |
WO (1) | WO2022238739A1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0024489D0 (en) | 2000-10-06 | 2000-11-22 | Reckitt Benckiser Uk Ltd | Improvements in or relating to organic compositions |
US6849586B2 (en) | 2001-10-26 | 2005-02-01 | S. C. Johnson & Son, Inc. | Hard surface cleaners containing chitosan |
KR100687567B1 (en) | 2002-03-20 | 2007-02-27 | 쇼와 덴코 가부시키가이샤 | Chitosan-containing composition for improving disease resistance and growth of plants |
US7968122B2 (en) | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
WO2005067878A1 (en) * | 2004-01-13 | 2005-07-28 | Vanson Halosource, Inc. | Polysaccharide alcohol antiseptic gel |
US9132296B2 (en) | 2007-05-17 | 2015-09-15 | Ag Essence | Antimicrobial solution and methods of making and using the same |
US20090117213A1 (en) * | 2007-11-06 | 2009-05-07 | Clermont Beaulieu | Stable solutions having antiviral, antibacterial and hemostatic properties and methods of making thereof |
-
2021
- 2021-05-11 PT PT117220A patent/PT117220A/en unknown
- 2021-05-31 WO PCT/IB2021/054772 patent/WO2022238739A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2022238739A1 (en) | 2022-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Siems et al. | β‐Carotene cleavage products induce oxidative stress in vitro by impairing mitochondrial respiration | |
BR112021006613A2 (en) | compositions with enhanced deposition of surfactant-soluble anti-dandruff agents | |
BRPI0212455B8 (en) | compound derived from phenethanolamine for the treatment of respiratory diseases, pharmaceutical formulation, combination, and use thereof | |
BR112018010505A2 (en) | human milk oligosaccharide mixture (hmos) | |
BR112019007682A2 (en) | stable low viscosity compact shampoo products and viscosity reducing agent | |
BRPI0717673B8 (en) | composition of oligogalacturonans, biomaterial and textile | |
BRPI0608399A2 (en) | aqueous disinfectants and sterilizers | |
BR0315720A (en) | Compound, method for the prophylaxis or treatment of a clinical condition in a mammal, pharmaceutical formulation, combination, use of a compound, process for the preparation of a compound, and, intermediate | |
BRPI0712964A2 (en) | process for the eradication of pathogens comprising generating molecular iodine at the site | |
BR112015013861A2 (en) | long acting protein compositions and methods | |
BRPI0809891C8 (en) | sanitizing foam dispenser, product and compositions | |
BR112015011497A2 (en) | compound, pharmaceutical formulation, combination product, and method of treating a disease | |
BR0313723A (en) | Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity | |
BR112014010907A2 (en) | surface treatment compositions including protective salts | |
AR058136A1 (en) | PREVENTION OF DISEASES IN NEONATES BORN BY CESAREA | |
BRPI0508177A (en) | compound, process for the production of compound, pharmaceutical composition, use of compound method for treating a disease and combination product | |
BR112022001413A2 (en) | Cannabidiol preparation, and, method for treating a disease modification in a patient suffering from dravet syndrome | |
BR112017012682A2 (en) | process for improving muscle portions and products | |
BR112013024034A2 (en) | pharmaceutical composition for treating oral cavity disease comprising rebamipide | |
BR112020020131A8 (en) | ANTI-DEGRADANT MIXTURE, USE AND USEFUL ARTICLE | |
BR112021024063A2 (en) | Identification and selection of a plant starting material of plant chondroitin sulfate and hyaluronic acid, and transformation of such plant starting material to obtain ingredients for use in foods, supplements, medical devices or pharmaceuticals | |
BR112015004843A2 (en) | use of a combination of at least two selected compounds of baclofen, acamprosate, cinacalcet, mexiletine, sulfisoxazole and torasemide, or sustained release salt, prodrug (s) or formulation (s) | |
BR112022024156A2 (en) | ANTHELMINTIC HETEROCYLIC COMPOUNDS | |
BR112018015669A2 (en) | process for producing a composition, compositions and uses of at least one compound having a conjugated aromatic structure | |
BRPI0801239A2 (en) | use of one or more benzopyranones, pharmaceutical composition and method for the prevention or treatment of monoamine oxidase-associated diseases, disorders and disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 20230116 |